About MITOSENSE INC
MitoSense, Inc. is a biotechnology company focused on developing Mitochondria Organelle Transplantation (MOT) technology for the treatment of neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's. The company holds exclusive licensing to MOT and has demonstrated proof of concept for this cellular biotherapy.
Mitochondria Organelle Transplantation (MOT) technology developmentCellular biotherapy research and developmentNeurodegenerative disease treatment innovation
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MITOSENSE INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.